PACTR201904797961340招募中3 期
Empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia: a multicenter, open-label randomized controlled clinical trial
Servicio Madrileno de Salud Fundacion para la Investigacion Biomedica Hospital Universitario 12 de Octubre0 个研究点目标入组 624 人开始时间: 2019年4月9日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 624
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1 Month(s) 至 23 Month(s)（—）
- 性别
- All
入选标准
- •1.Age 28 days to 365 days of age
- •2.Pneumonia defined as chest indrawing or fast breathing for age, for infants 28 to 60 days of age =60 breaths per minute and for infants 61 to 365 days of age, =50 breaths per minute.
- •3.Current hospitalization due to pneumonia with criteria for parenteral antibiotics (1 or more criteria)
- •a)Chest indrawing with HIV infection
- •b)No improvement with oral treatment.
- •c)One or more danger signs according to WHO
- •-Central cyanosis or saturation of O2 <90%
- •-Severe respiratory distress, e.g. grunting or very severe chest indrawing
- •-Signs of pneumonia with a general danger sign:
- •-Unable to drink or breastfeed
- •-Persisting vomiting
- •-Convulsions in the last 24 hours
- •-Lethargic or unconscious
- •-Stridor while calm
- •-Severe malnutrition
- •4.HIV-confirmed infection (with at least one molecular method: DNA PCR or RNA PCR/viral load).
- •5.Informed consent obtained
排除标准
- •1.Clinical TB (pulmonary or extrapulmonary) diagnosis, defined as the necessity of TB-T prescribed by a physician, at the moment of randomization
- •2.Known bacteriologically confirmed TB case (at least one biological specimen positive by culture or Xpert MTB/RIF) at the moment of randomization
- •3.Patient previously treated for TB or currently on treatment for TB
- •4.Documented evidence of close TB exposure (household contact of a patient with documented TB during the lifetime of the child, or currently receiving TB-T)
- •5.Pure wheezers defined as a clear clinical improvement after a bronchodilator test (give a challenge of rapid-acting inhaled bronchodilator for up to three times 15-20 minutes apart. Count the breaths and look for chest indrawing again, and then re-classify)
- •6.Active malignancies
- •7.Systemic immunosuppressive medications. Steroids will be considered to be immunosuppressing only if >2 mg/kg of prednisone or equivalent during >15 days
- •8.Evidence of condition other than HIV and pneumonia which precludes, to the judgment of the clinical researcher, enrollment in this trial due to risk for the patient. In case of doubt, the Trial Management Team will be contacted to assess eligibility
- •9.Less than 2.5 kg of weight
- •10.Hb <6 g/dL in the screening blood test or in a test done in the last 48 hours. Transfusion is permitted to achieve >6 g/dL if the patient’s state allows it. In case a transfusion is administered, the patient can be enrolled
- •11.Neutropenia <500 /mm3 in the screening blood test or in a test done in the last 48 hours. Repeating the test is allowed to check eligibility
研究者
相似试验
已完成
2 期
Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe PneumoniaHIV/AIDSPneumoniaCytomegalovirus InfectionsTuberculosisNCT03915366Hospital Universitario 12 de Octubre563
招募中
不适用
Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant RecipientsLung DiseasesNCT06494033University of Miami100
已完成
不适用
Effect of ganciclovir eye-drops for corneal endothelitis caused by cytomegalovirus infectioCytomegalovirus coreal endotheliitisCytomegalovirus, Coreal endotheliitisJPRN-jRCTs021180030Tando Toshio10
已完成
3 期
CONgenital Cytomegalovirus: Efficacy of antiviral treatment in a non-Randomized Trial with historical control groupcongenital cytomegalovirus (CMV)100407921001924310012562NL-OMON41461eids Universitair Medisch Centrum50
进行中（未招募）
1 期
Efficacy of antiviral treatment of congenital cytomegalovirus in a non-randomized trial with historical control groupCongenital cytomegalovirus infection.Sensorineural Hearingloss.MedDRA version: 18.0Level: LLTClassification code 10010420Term: Congenital CMV infectionSystem Organ Class: 100000004850EUCTR2013-003068-30-NLMC50